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Sudden Death in Hospitalized Patients: Cardiac Rhythm Disturbances
Detected by Ambulatory Electrocardiographic Monitoring
IOANNIS P. PANIDIS, MD, * JOEL MORGANROTH, MD, FACC*t
Philadelphia. Pennsylvania
To determine the cardiac rhythm disturbances under-
lying sudden death, 15 patients (14 inpatients and 1 out-
patient) who had cardiac arrest unexpectedly while
undergoing ambulatory electrocardiographic monitor-
ing were identified. Heart disease was present in 11 pa-
tients and 7 patients were admitted to the hospital with
chest pain before sudden cardiac death occurred.
The terminal event at the time of cardiac arrest in 3
(20%) of the 15 patients was a brady arrhythmia ex-
pressed as complete heart block; none survived. A ven-
tricular tachyarrhythmia was the precursor of sudden
cardiac death in the remaining 12 patients (80%). Two
of these 12 had slow ventricular tachycardia and both
died. Five had polymorphous ventricular tachycardia
associated with prolonged QT interval (torsade de pointes)
and three were receiving a class 1 antiarrhythmic agent.
This rhythm degenerated into ventricular fibrillation in
Sudden cardiac death is a common mode of mortality in the
western world and, thus, a major problem confronting mod-
em cardiology (1,2). Ambulatory electrocardiographic
(Holter) monitoring has proved a useful method for the
detection of occult arrhythmias and risk stratification of
patients subject to sudden cardiac death (3,4). There have
been few case reports (4-12) of patients who died suddenly
while fortuitously undergoing ambulatory electrocardio-
graphic monitoring. Such patients can provide insight into
the rhythm disturbances underlying sudden cardiac death.
In this report, we describe the findings in IS patients
who had sudden cardiac death while undergoing ambulatory
electrocardiographic monitoring in an attempt to define more
precisely the abnormal rhythms preceding this event and the
factors that may lead to their prevention.
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one patient; four of the five patients survived after elec-
trical cardioversion. One patient had ventricular tachy-
cardia followed by asystole. Four patients had ventric-
ular flutter (rate > 250/min) that degenerated into
ventricular fibrillation in each case; only one of these
four patients survived after cardioversion. Frequent (>
30/h) premature ventricular complexes were present in
9 of 10 patients with ventricular tachycardia or flutter
and R on T phenomenon was seen in only 1 patient.
In conclusion, a ventricular tachyarrhythmia is usu-
ally found on Holter monitoring during sudden cardiac
death in hospitalized patients; torsade de pointes (po-
lymorphous ventricular tachycardia) is a frequent cause
of sudden death in these patients. Ventricular fibrillation
is always preceded by ventricular tachycardia or ven-
tricular flutter.
Methods
Patients. Between 1978 and 1981, we searched ap-
proximately 38,500 ambulatory (24 hour) electrocardio-
graphic (Holter) monitoring reports and identified IS pa-
tients who had had sudden cardiac death during the monitoring
session. These IS patients included 4 men and II women
ranging in age from 53 to 89 years (Table I). Fourteen of
the IS patients were hospital inpatients during their episode
of cardiac arrest and I patient was an ambulatory outpatient.
Ambulatory electrocardiographic monitoring. Am-
bulatory Holter monitoring was conducted using the Avion-
ics 445 two channel recorder, and analysis was conducted
by an independent commercial research firm (Cardio Data
Systems of the United Medical Corporation). Measures of
repeatability and accuracy in this center were employed
using hand-counted tapes in real time, containing abnormal
rhythms that were inserted into the reading schedules in a
blinded fashion; this is a routine quality control method used
by this center. QT interval measurements were taken from
the Holter monitoring recording; however, they may be
inaccurate because it is often difficult to separate a U wave
in the bipolar chest leads. The QT interval was corrected
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Table 1. Clinical and Holter Monitor Findings in 15 Hospitalized Patients With Sudden Cardiac Death
Previous
Age(yr) Cardiac Adrruttmg Antiarrhythmic VPB Cardiac Arrhythmia
Case &Sex History Diagnosis Drugs Frequency on Holter Outcome
83 F CAD, Chest Pain, None o to 5/h 3° AV block, duration 5 Recurrence of chest
HTN inferior wall min; ST elevation; pain, ECG =
ischemia on idioventricular rhythm new IMI, RBBB;
ECG death 2 days after
admission
2 ?F Unknown SepSIS, Unknown o to lOth 3° AV block; junctional Death
dehydration rhythm; duration 3 rrun;
idtoventricular rhythm,
duration 6 min
3 53 F HTN, Acute infenor MI, Digoxin. I to 14/h ST elevation; 3° AV block; Death 6 days after
CHF VA disopyrarmde Junctional rhythm; admission
idioventricular rhythm
4 75 F None Chest pain None I I to 34/h, 4 Slow VT; ST elevation; Death I day after
couplets idioventricular rhythm admission
5 82 M VA, Dehydration, Digoxm (level 4.2 50 to 500/h, 2 Junctional rhythm; slow Death 9 days after
COPD hypotension ng/ml). couplets VT, idioventncular admission
(cause quinidine rhythm
unknown)
6 84 F CAD, Dyspnea Digoxin, 86 to 200/h, 2 Polymorphous VT: DC shock-survived
CHF quinidine. K: couplets coupling interval 480
VA, VF 3.2 rns, rate 230 to 280/mm,
duration 162 s;
VF, duration 90 s
7 89 F ? ? 17 to 499/h, 8 Polymorphous VT: DC shock-survived
couplets coupling interval 660 to
760 rns, rate 190 to
195/min, duration 10 s
to 2'/, nun
8 64M CAD, Dyspnea, ECG = Digoxin, procan- 790 to 2200/h Polymorphous VT: DC shock-
CHF old AMI + IMI SR (pronestyl) Frequent coupling interval 560 survived; died 4
VA (high levels) couplets, ms, rate 175 to 200/mm, days later from
tnplets duration 10 min, 9 s cardiogemc shock
9 ?M CAD, Qumidine, 13 to 353/h Polymorphous VT: Death
CHF digoxin couplets, coupling interval 550
VA tnplets ms, rate 250/mm,
duration 225 s;
idioventricular rhythm,
duration 5 min
10 67 F CAD, Syncope Digoxin 5 to 1500/h Polymorphous VT: DC shock-survived
HTN couplets couplmg interval 560 (5 days after
ms, rate 220/min, admission). Died
duration 60 s suddenly out of
hospital after
several months on
pronestyl-norpace
II 79 F CAD, Subendocardial MI Digoxin, 5 to 100/h ST elevation; VT: coupling Recurrent chest
HTN pronestyl interval 500 ms, rate pain, ECG acute
160 to l70/min, duration 1M!, death 12
150 s; idioventncular days after
rhythm admission
12 72F HTN Acute infenor MI None < 30/h, I V Fl: coupling interval 440 Death 16 days after
couplet ms, rate 270/min, MI
duration 72 s;
VF, duration 12 min
13 72F Chest pain, ECG 26 to 54/h, 4 V Fl (early cycle VPB): Death I day after
= normal couplets coupling interval 260 admission
ms, rate 280/min,
duration Is,
VF, duration 18 mm
(continued)
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Table 1. Clinical and Holter Monitor Findings in 15 Hospitalized Patients With Sudden Cardiac Death (continued)
Previous
Age(yr) Cardiac Admitting Antiarrhythmic
Case & Sex History Diagnosis Drugs
14 55 M CCM.VA Outpatient Digoxin
15 80 F CAD Acute inferior MI Digoxin, K:3.2
VPB
Frequency
310 to 940/h
frequent
couplets,
triplets
>1000/h,
frequent
couplets,
tnplets
Cardiac Arrhythmia
on Holter
V FI: coupling interval 400
ms, rate 270/min,
duration 15 s,
VF duration 4 mm 55 s
V FI: couplmg interval 440
ms, rate 270 to 280/min,
duration 210 s,
VF duration 60 s
Outcome
Died at home
DC shock-survived
30 days after
admission; died 6
days later in
cardiogenic shock
AMI = anterior myocardial infarction, AV = atrioventricular; CAD = coronary artery disease; CCM = congestive cardiomyopathy; CHF =
congestive heart failure; COPD = chronic obstructive pulmonary disease; DC = direct current; ECG = electrocardiogram; HTN = hypertension; IMI
= inferior myocardial infarction; MI = myocardial mfarction; RBBB = right bundle branch block; VA = ventricular arrhythmias; VF = ventncular
fibrillation; V FI = ventricular flutter; VPB = ventricular premature beats; VT = ventricular tachycardia; ? = not available.
for heart rate (QTc interval) using Bazett's formula, and the
upper limit of normal was 440 ms.
Ventricular tachycardia was defined as "slow" if the
heart rate was 120/min or less and considered polymorphous
if at least three different configurations were seen in the
episode of tachycardia. Ventricular flutter was defined as
the presence of a regular ventricular tachyarrhythmia with
a heart rate of 250/min or more.
Antiarrhythmic drugs. Nine (75%) of the 12 patients
were taking digoxin. The digoxin level was available in
seven patients and was within therapeutic range in six. At
the time of their cardiac arrest, six patients were taking
other drugs in addition to digoxin: quinidine (three patients),
procainamide (two patients) and disopyramide (one patient)
Table 2. Terminal Rhythm in 15 Patients With Sudden Death
During Holter Monitoring
CHB = complete heart block; PVT = polymorphous ventricular
tachycardia; VF = ventncular fibrillation; V Fl = ventricular flutter; VT
= ventricular tachycardia. The number of patients who survived is noted
in parentheses.
4 VF(I)
V FI
(> 250/mm)
4(1)
I
VT
8(4)
Slow VT~i!~ PVT
« l20/min) (100 to 250/min) 5(4)
~m lro) I
I VF(l)
CHB
3(0)
Sudden death
15 patients (5)
/'"14 inpatients I outpatient
Bradyarrhythmia / ~ Ventricular arrhythmia
3 patients(O) 12 patients (5)
I
Results
Clinical findings (Table 1). In 12 of the 15 patients,
complete clinical evaluation by hospital records was ob-
tained, but only limited information was available in the
remaining 3 patients. Eleven patients (92%) had known
prior heart disease, 7 had coronary artery disease diagnosed
as either angina pectoris or prior myocardial infarction, 5
had hypertension, 5 had congestive heart failure and 1 had
congestive cardiomyopathy. Five of the 12 patients had
known prior ventricular arrhythmias and only 1 patient had
no prior history of cardiac disease and was admitted with
the first episode of chest pain.
Patients with myocardial infarction. Chest pain was
the admission diagnosis in 7 of the 12 hospitalized patients.
Four of these seven patients developed evidence of an acute
myocardial infarction (three inferior wall and one suben-
docardial). All four patients had a cardiac arrest 6 to 30
days after admission while they were in stable condition out
of the intensive care unit and two had ST elevation on Holter
monitor or electrocardiogram before sudden death. The other
three patients with chest pain on admission but no evidence
of acute myocardial infarction had a cardiac arrest within I
to 2 days after admission. These three patients represent a
subset of individuals with unstable angina terminating in
sudden electrical death. Two of these three patients had ST
elevation by electrocardiogram or Holter monitoring.
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Figure 2. Patient4. Sequentialbut notcontinuous Holtermonitor
recordings during sudden cardiac death. Slow ventricular tachy-
cardia at a rate of 70/min is seen (panel A). ST segment elevation
and frequent premature ventricular complexes, two or three in a
row, are observed (panel B), followed by idioventricular rhythm
with further ST segment elevation (panel C) and, finally, cardiac
asystole (panel D). This patient died.
2 had slow ventricular tachycardia or accelerated idioven-
tricular rhythm (rate 70 to 100/min); ventricular tachycardia
alone was present in 6 and ventricular flutter preceding but
terminating in ventricular fibrillation was present in the re-
maining 4 patients.
Slow ventricular tachycardia. Among the two patients
(Patients 4 and 5) with slow ventricular tachycardia, one
was admitted 1 day before cardiac arrest with chest pain but
had no evidence of acute myocardial infarction. ST segment
elevation was noted before the development of slow ven-
tricular tachycardia (Fig. 2). The second patient with a his-
tory of chronic obstructive pulmonary disease was admitted
with dehydration and was receiving a combination of di-
goxin and quinidine. Holter monitoring revealed frequent
ventricular ectopic beats (from 50 to 500/hour). The digoxin
level (drawn 3 days before cardiac arrest) was elevated.
Ventricular tachycardiaor ventricular flutter (Table3).
Polymorphous ventricular tachycardia was the terminal rhythm
in 5 (36%) of 14 patients (Patients 6 to 10) with an in-
hospital cardiac arrest, and 3 of these 5 patients had conges-
tive heart failure and were taking either quinidine (2 patients)
or procainamide (l patient). The QTc interval was prolonged
in all five patients (Fig. 3). Four of the five patients with
polymorphous ventricular tachycardia were successfully
resuscitated.
Five patients had either a nonpolymorphous ventricular
tachycardia (Patient 11) or ventricular flutter (Patients 12
to 15) at the onset of their cardiac arrest associated with
either an acute or recent (within 30 days) myocardial in-
farction in three of the five patients (Fig. 4). Only one of
. '"
,f \V--r,
I ~
: rJc
Figure 1. Patient 3. Sequential but not continuous Holter monitor
recordingsduring suddencardiacdeath. Normal sinusrhythmwith
first degree atrioventricular (AV) block is followed by AV dis-
sociation(panel A). Note the ST segmentelevation and wideQRS
complexduringcompleteheartblock(panel B). Shortlythereafter,
idioventricular rhythmwith further ST segmentelevation and wid-
ening of QRS complex occurred (panel C) followed by cardiac
asystole. This patient died.
(Table 1). Plasma drug levels during treatment with these
agents were available in only one patient taking sustained
release procainamide; in this patient the N-acetyl-procain-
amide (NAPA) level was 13.0 mg/liter and the procainamide
level was 13.5 mg/liter on the day of cardiac arrest. The
QTc interval was prolonged in four of the six patients taking
antiarrhythmic drugs.
Findings on Holter monitoring. Sinus rhythm was
present in 11 patients, atrial fibrillation in 3 and atrial paced
rhythm in 1. The QTc interval was normal in 9 of the 15
patients and ranged from 360 to 440 ms. In six patients with
a prolonged QTc interval (> 440 ms), the range was 460
to 660 ms.
Table 2 shows the terminal rhythm in these 15 patients
who had sudden cardiac death. A bradyarrhythmia was the
terminal event on Holter monitoring in 3 (20%) of the 15
patients, whereas ventricular tachyarrhythmia was present
in the remaining 12 patients (80%). Ten (67%) of the IS
patients did not survive the cardiac arrest; the remaining 5
(33%) were resuscitated by electrical cardioversion.
Bradyarrhythmias. In the three patients with bradyar-
rhythmia (Patients 1 to 3), complete heart block with junc-
tional or idioventricular rhythm was seen. All three had only
rare ventricular premature complexes (0 to 14/hour) on the
Holter monitor recording before their cardiac arrest, and ST
segment elevation was noted as the terminal event in two
patients (Fig. 1). One patient had a recent inferior myo-
cardial infarction and the second had an acute inferior myo-
cardial infarction and new right bundle branch block de-
tected by electrocardiogram the day of cardiac arrest. All
three patients died.
Ventricular tachyarrhythmias (Table 2). Of the 12
patients with ventricular arrhythmias as the terminal rhythm,
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Table 3. Clinical and Electrocardiographic Features of Patients With Polymorphous and Nonpolymorphous Ventricular Tachycardia
or Ventricular Flutter
Polymorphous VT
(5 patients)
Nonpolymorphous VT or V FI
(5 patients)
History of congestive heart failure
History of acute or recent MI
(within 30 days)
Type I antiarrhythmic drugs
Prolonged QTc interval (>440 ms)
Rate of VT
R on T phenomenon
Frequent (>30/h) VPBs on Holter monitor
Maximal duration of VT
Outcome of VT
Interrupted by DC cardioversion
Degenerated to VF
Asystole
Resuscitated by DC cardioversion
3
o
3
5
175 to 280/min
None
5
60 s-IO min, 9 s
3
1
1
4
I
3
I
1
160 to 280/min
1
4
1 s-3 min, 30 s
o
4
1
1
DC = direct current; MI = myocardial infarction; VF = ventricular fibrillation; V FI = ventricular flutter; VPBs = ventricular premature beats;
VT = ventricular tachycardia.
these five patients was successfully resuscitated. Frequent
(> 30/hour) premature ventricular beats were seen in 9 of
the 10 patients with ventricular tachycardia or ventricular
flutter. No change in the frequency or complexity of ven-
tricular arrhythmia, however, was observed before the ter-
minal ventricular tachyarrhythmia. R on T phenomenon was
observed in only I of the 10 patients.
Ventricular tachycardia or flutter always preceded ven-
tricular fibrillation (Table 3). The duration of the tachy-
cardia ranged between I and 10 minutes in the five patients
with polymorphous ventricular tachycardia. It was inter-
rupted by cardioversion in three patients, followed by asys-
tole in one and degenerated into ventricular fibrillation in
one. It lasted between I second and 3.5 minutes in the five
patients with nonpolymorphous ventricular tachycardia or
ventricular flutter, was followed by asystole' in one and
degenerated into ventricular fibrillation in four. The shortest
duration of a ventricular tachyarrhythmia (I second) before
degeneration into ventricular fibrillation was observed in the
episode initiated by an early cycle ventricular ectopic beat
(Fig. 5).
Overall, ventricular fibrillation occurred in 5 (33%) of
the 15 patients, and 2 of these 5 survived after cardioversion.
The duration of ventricular fibrillation before cardiac asys-
tole occurred in these five patients ranged from 60 seconds
to 18 minutes. Both patients in whom ventricular fibrillation
was interrupted successfully by direct current shock sur-
vived; the duration of the ventricular fibrillation was 90 and
60 seconds, respectively.
Discussion
Primary cardiac arrest without prior circulatory collapse
is usually due to an arrhythmia and most frequently occurs
out of the hospital (1,13). The electrical events leading to
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Figure3. patient 8. Sequential but not continuous Holter monitor
recordings during sudden cardiac death. Normal sinus rhythm with
frequent, multiform premature ventricular complexes in couplets
or triplets are seen in panel A. Note the prolonged QT interval
(QTc 620 ms). This patient had toxic levels of procainamide and
N-acetyl-procainamide. A polymorphous ventricular tachycardia
(torsade de pointes) at a rate 175 to 200/min (panels B and C)
was followed by a more uniform ventricular tachycardia' (panel
D) and was interrupted after a total duration of 10 minutes and 9
seconds by direct current cardioversion (panel E, arrow). This
patient survived.
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Figure 4. Patient 15,Sequential butnotcontinuous Holtermonitor
recordings during sudden cardiac death, Atrial fibrillation with
frequent, multiform premature ventricular contractions is seen(panel
A) followed by ventricular flutter at a rate of 270 to 280/min
initiated with a coupling interval of 440 ms, Ventricular flutter
lasted for 210 seconds (panel B) before it degenerated into ven-
tricularfibrillation (panel C), Electrical cardioversion (arrow) was
applied after 60 seconds of ventricularfibrillation (panel D), This
patient survived,
1 t. "- l .
D"'-~~
••• • 10 _ r .
, I I
B
A
c""'
Figure 5. Patient 13,Sequential butnotcontinuous Holtermonitor
recordings during suddencardiacdeath. Normal sinusrhythmwith
firstdegree atrioventricular block is seen (panel A);one premature
ventricular beat with a coupling interval of 520 ms IS present.
Ventricular flutter at a rate of 280/mlll was initiated with a short
coupling interval of 260 ms and degenerated into ventricular fi-
brillation after I second (panel B). Coarse, and, subsequently,
fine ventricular fibrillation (panels C and D) lasted 18 minutes
before cardiac asystole occurred. This patient died.
to that found in some pathologic (19) and clinical studies
(13,20) in patients who died suddenly out of the hospital.
Rhythm disturbances leading to sudden cardiac
death. Ventricular fibrillation has been considered the most
common cause of death in patients with out of hospital
sudden cardiac death (20-22). Adgey et al. (22) reported
that when an electrocardiogram was obtained within 4 min-
utes of the onset of symptoms of cardiac arrest, the majority
of patients (91 %) had ventricular fibrillation and within 4
minutes 82% manifested cardiac standstill. Ventricular fi-
brillation was the most frequent rhythm reported in the cases
(4-12) in which a patient had a Holter monitor recording
during cardiac arrest. However, a review of these cases
reveals that ventricular tachycardia or ventricular flutter al-
ways preceded ventricular fibrillation. A ventricular ar-
rhythmia was related to sudden cardiac death in 80% of the
patients in our series.
Bradyarrhythmias. In this study, 20% of the sudden
deaths were associated with bradyarrhythmias expressed in
all patients as complete heart block with junctional or idiov-
entricular rhythm. This is similar to the 15 to 25% incidence
of bradyarrhythmias found in out of hospital sudden death
victims usually expressed as sinus bradycardia or sinus arrest
(20,21,23). None of our patients with bradyarrhythmias could
be resuscitated and a uniformly fatal prognosis has been
also reported by others (23).
Ventricular arrhythmias. Slow ventricular tachy-
cardia. This arrhythmia was seen in two patients and may
represent an escape rhythm and not necessarily a primary
. '
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sudden cardiac death have been recorded by resuscitation
teams in only a small number of patients, usually within
several minutes after sudden collapse (1). Fortuitous am-
bulatory electrocardiographic monitoring at the onset of such
episodes has been reported in only a few out of hospital
patients (4-8) and in-hospital patients (9-11) who had suf-
fered sudden cardiac arrest. In the present study, we discuss
the clinical features and the electrical events recorded by
ambulatory monitoring in 15 patients (14 inpatients and 1
outpatient) who had sudden cardiac death without associated
general circulatory failure. Because the majority of patients
in this study were hospitalized with a variety of clinical
problems during their cardiac arrest, our findings may not
apply to patients who die suddenly out of the hospital. The
large number of women in our study may represent a sam-
pling error.
Underlying cardiac disease. Clinical cardiovascular
disease is usually present before sudden cardiac death in the
majority of patients (13-15), We observed that 92% of our
patients had a previous history of heart disease and that the
majority had coronary artery disease, Hypertension and
congestive heart failure (observed in 41% of our patients)
are risk factors often associated with a high prevalence of
sudden cardiac death in patients with coronary artery disease
(16-18).
Four of the 15 patients who died suddenly had an acute
myocardial infarction as evident by ST elevation on Holter
monitoring or electrocardiogram; thus, prevalence is similar
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cause of sudden cardiac death. Slow ventricular tachycardia
was associated with an acute myocardial infarction in one
patient and digitalis toxicity in another who was also re-
ceiving quinidine. The incidence of toxic manifestations of
digitalis in hospitalized patients varies from 8 to 35% and
mortality is 3 to 12% (24). Digoxin levels and toxicity may
be enhanced in the presence of quinidine (25).
Ventricular tachycardia or ventricular flutter. Poly-
morphous ventricular tachycardia. This arrhythmia, asso-
ciated with prolonged QT interval (torsadede pointes) (26-28),
was seen in five (33%) of our hospitalized patients with
sudden cardiac death. It most frequently results from an-
tiarrhythmic agents such as quinidine (10,29), procainamide
(28), disopyramide (30) and other similar drugs. Three of
the five patients in our series were taking either quinidine
or procainamide and had congestive heart failure. Signifi-
cant left ventricular dysfunction, which already places an
individual at high risk for ventricular arrhythmias (31,32),
appears also to be a predisposing factor for the development
of torsade de pointes, which can be associated with thera-
peutic blood levels of the antiarrhythmic agent (10). Hy-
pokalemia has also been associated with torsade de pointes
(27,28) and may be a contributing factor in one patient in
our series. On the other hand, typical torsade de pointes
may develop in patients with organic heart disease in the
absence of electrolyte disturbances, antiarrhythmic drug
therapy or acute ischemia (26), as seen in one of our patients.
Eighty percent of patients with torsade de pointes could
be resuscitated with direct current cardioversion compared
with only 20% of patients with nonpolymorphous ventric-
ular tachycardia, possibly related to the observation that
torsade de pointes degenerated into ventricular fibrillation
less frequently. Torsade de pointes, therefore, is a frequent,
potentially fatal rhythm associated with sudden cardiac death
in hospitalized patients, especially in the setting of conges-
tive heart failure and the use of membrane-active antiar-
rhythmic agents.
Nonpolymorphous ventricular tachycardia. This rhythm
was seen in five patients, four of whom had ventricular
flutter that degenerated into ventricular fibrillation, and one
of whom had nonpolymorphous ventricular tachycardia
leading to asystole. Only one of the five patients survived.
Four of the five patients had frequent ventricular ectopic
beats on Holter monitoring (> 30/hour). Only one of these
patients demonstrated the R on T phenomenon (Table 3).
Our findings agree with other studies that demonstrated that
frequent and complex ventricular arrhythmia represented an
independent risk factor for sudden cardiac death in patients
with coronary artery disease (33), especially after acute
myocardial infarction (34-36). Frequency or complexity of
ventricular arrhythmia, however, was not clearly increased
just before the terminal ventricular arrhythmia.
Ventricular fibrillation. In the setting of acute myo-
cardial infarction, ventricular fibrillation is frequently ob-
served in patients with overt congestive heart failure or
shock and carries a poor prognosis (37,38). It can also occur
in 5 to 10% of patients during an otherwise uncomplicated
postmyocardial infarction course (36,37) and may not have
an unfavorable prognosis (38). The R on T phenomenon
was frequently implicated in the initiation of ventricular
fibrillation in this setting (36,39) and also in ambulatory
patients with coronary artery disease and sudden cardiac
death during Holter monitoring (4-8). Late coupling ven-
tricular ectopic beats have been noted in other studies (10,
31,40) to initiate ventricular tachycardia as was also ob-
served in our study.
Overall, ventricular fibrillation was seen in 5 (33%) of
15 patients and was preceded by rapid polymorphous ven-
tricular tachycardia in 1 patient and by ventricular flutter in
4 patients. Thus, ventricular fibrillation does not occur as
the primary event in sudden cardiac death, but is usually
preceded by a ventricular tachyarrhythmia. Ventricular fi-
brillation has a fatal outcome unless electrical cardioversion
is applied early, although a few cases have been reported
in which it resolved spontaneously (10,41). Two (40%) of
our five patients were successfully resuscitated by cardio-
version after 60 and 90 seconds, respectively, of ventricular
fibrillation.
Clinical implications. Our study indicates that ventric-
ular tachyarrhythmias are most commonly responsible for
sudden cardiac death in hospitalized patients. Although an-
tiarrhythmic drug therapy may be used for the suppression
of malignant ventricular arrhythmias with the hope of pre-
venting sudden death, fatal arrhythmia, such as torsade de
pointes, may be induced by these agents and, therefore,
patients taking antiarrhythmic agents must be carefully
observed.
We thank Leonard N. Horowitz, MD for his review of this manuscnpt
and Jan Howard for its preparation.
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